{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/RESULTSCellMinerCDB",
      "@type": "sc:SoftwareApplication",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_0208"
        },
        {
          "@id": "edam:topic_3360"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1158/1078-0432.CCR-19-0419"
        },
        "pmcid:PMC6801079",
        "pubmed:31409613"
      ],
      "sc:description": "> MEDIUM CONFIDENCE! | > COMMON LINK WITH (PUB. & NAME DIFFERENT) bio.tools/CellMinerCDB (DISCOVER.NCI.NIH.GOV/cellminercdb), bio.tools/mammalian_gene_collection (NCI.NIH.GOV), bio.tools/rcellminer (NCI.NIH.GOV/cellminer), bio.tools/cgap (NCI.NIH.GOV), bio.tools/pid (NCI.NIH.GOV) | > CORRECT NAME OF TOOL COULD ALSO BE 'DESIGN:CellMinerCDB', 'indenoisoquinolines', 'LMP400 olaparib', 'LMP400' | The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib | CellMiner Cross Database (CellMinerCDB) is the first web application to allow translational researchers to conduct analyses across all major cancer cell line pharmacogenomic data sources from NCI-DTP NCI-60, Sanger GDSC, and Broad CCLE/CTRP | Skip over navigation CellMiner NCI-60 NCI/DCTD/DTP",
      "sc:name": "RESULTS:CellMinerCDB",
      "sc:url": "http://discover.nci.nih.gov/cellminercdb"
    },
    {
      "@id": "https://doi.org/10.1158/1078-0432.CCR-19-0419",
      "@type": "sc:CreativeWork"
    }
  ]
}